Your browser doesn't support javascript.
loading
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist ; 18(3): 271-2, 2013.
Article in En | MEDLINE | ID: mdl-23485624

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Esophageal Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: United States